SCHEMBL6867028

SCHEMBL6867028

C=CCOc1c(C=NOC)c(=O)oc2c(C)c(O[C@@H]3OC(C)(C)[C@H](OC)[C@H](O)[C@H]3O)ccc12

nearest known ligand 0.51

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
HSP90AB1 P08238 8/20 0.51
HSP90AA1 P07900 7/20 0.51
MAP1LC3B Q9GZQ8 2/20 0.40
MAP1LC3A Q9H492 2/20 0.40
POLQ O75417 1/20 0.40
ALB P02768 1/20 0.40
KDR P35968 1/20 0.40
ABCG2 Q9UNQ0 1/20 0.40
KDM4E B2RXH2 2/20 0.39
LMNA P02545 1/20 0.39
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39
ALDH1A1 P00352 1/20 0.37
HPGD P15428 1/20 0.37
TSHR P16473 1/20 0.37
HSD17B10 Q99714 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6867022 1.00 HSP90AB1 (0.51) HSP90AB1HSP90AA1MAP1LC3BMAP1LC3APOLQ
SCHEMBL6866195 0.86 HSP90AB1 (0.52) HSP90AB1HSP90AA1MAP1LC3BMAP1LC3APOLQ
SCHEMBL6866197 0.86 HSP90AB1 (0.52) HSP90AB1HSP90AA1MAP1LC3BMAP1LC3APOLQ
SCHEMBL6870181 0.82 HSP90AB1 (0.49) HSP90AB1HSP90AA1MAP1LC3BMAP1LC3APOLQ
SCHEMBL7704161 0.82 HSP90AB1 (0.48) HSP90AB1HSP90AA1MAP1LC3BMAP1LC3APOLQ
SCHEMBL6867347 0.81 HSP90AB1 (0.49) HSP90AB1HSP90AA1MAP1LC3BMAP1LC3APOLQ
SCHEMBL6867344 0.81 HSP90AB1 (0.49) HSP90AB1HSP90AA1MAP1LC3BMAP1LC3APOLQ
SCHEMBL7709574 0.81 HSP90AB1 (0.48) HSP90AB1HSP90AA1MAP1LC3BMAP1LC3APOLQ
SCHEMBL7793409 0.81 HSP90AA1 (0.33) HSP90AB1HSP90AA1KDM4EALDH1A1HPGD
SCHEMBL6867185 0.81 KDM4E (0.51) HSP90AB1HSP90AA1MAP1LC3BMAP1LC3APOLQ

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6812331-B2 BACTERICIDES AVENTIS PHARMA S.A. (FR) 2004-11-02 US disclosed
US-6350733-B1 4-HYDROXYBENZOPYRAN-2-ONE DERIVATIVES; BACTERICIDES FOR STAPHYLOCOCCUS INFECTIONS; SKIN DISORDERS AVENTIS PHARMA S.A. (FR) 2002-02-26 US disclosed
US-20020010322-A1 New aromatic derivatives substituted by a ribose, their preparation process and their use as medicaments AVENTIS PHARMA S.A. 2002-01-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020010322-A1 New aromatic derivatives substituted by a ribose, their preparation process and their use as medicaments RPIA, CD38, PARP1 HSP90AB1 1949/4885HSP90AA1 2121/4885MAP1LC3B 2329/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.